Univ. of Wash.-spinout Icosavax raises $100M to fund vaccine development technology
GeekWire
APRIL 7, 2021
Icosavax creates virus-like particles with technology licensed from the University of Washington’s Institute for Protein Design. The company launched its COVID program in October, supported in part by $10 million from the Bill & Melinda Gates Foundation. Icosavax Photo).
Let's personalize your content